Literature DB >> 16439535

Regulation of human papillomavirus type 16 E7 activity through direct protein interaction with the E2 transcriptional activator.

Noor Gammoh1, Helena Sterlinko Grm, Paola Massimi, Lawrence Banks.   

Abstract

In order to ensure a productive life cycle, human papillomaviruses (HPVs) require fine regulation of their gene products. Uncontrolled activity of the viral oncoproteins E6 and E7 results in the immortalization of the infected epithelial cells and thus prevents the production of mature virions. Ectopically expressed E2 has been shown to suppress transcription of the HPV E6 and E7 region in cell lines where the viral DNA is integrated into the host genome, resulting in growth inhibition. However, it has been demonstrated that growth control of these cell lines can also occur independently of HPV E2 transcriptional activity in high-risk HPV types. In addition, E2 is unable to suppress transcription of the same region in cell lines derived from cervical tumors that harbor only episomal copies of the viral DNA. Here we show that HPV type 16 (HPV-16) E2 is capable of inhibiting HPV-16 E7 cooperation with an activated ras oncogene in the transformation of primary rodent cells. Furthermore, we demonstrate a direct interaction between the E2 and E7 proteins which requires the hinge region of E2 and the zinc-binding domain of E7. These viral proteins interact in vivo, and E2 has a marked effect upon both the stability of E7 and its cellular location, where it is responsible for recruiting E7 onto mitotic chromosomes at the later stages of mitosis. These results demonstrate a direct role for E2 in regulating the function of E7 and suggest an important role for E2 in directing E7 localization during mitosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16439535      PMCID: PMC1367139          DOI: 10.1128/JVI.80.4.1787-1797.2006

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  60 in total

Review 1.  Cell division.

Authors:  Jonathan M Scholey; Ingrid Brust-Mascher; Alex Mogilner
Journal:  Nature       Date:  2003-04-17       Impact factor: 49.962

2.  The human papillomavirus type 16 E6 and E7 oncoproteins independently induce numerical and structural chromosome instability.

Authors:  Stefan Duensing; Karl Münger
Journal:  Cancer Res       Date:  2002-12-01       Impact factor: 12.701

3.  The double bromodomain protein Brd4 binds to acetylated chromatin during interphase and mitosis.

Authors:  Anup Dey; Farideh Chitsaz; Asim Abbasi; Tom Misteli; Keiko Ozato
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-02       Impact factor: 11.205

Review 4.  The human papillomavirus E6 protein and its contribution to malignant progression.

Authors:  F Mantovani; L Banks
Journal:  Oncogene       Date:  2001-11-26       Impact factor: 9.867

5.  The HPV-16 E7 oncoprotein binds Skip and suppresses its transcriptional activity.

Authors:  T Prathapam; C Kühne; L Banks
Journal:  Oncogene       Date:  2001-11-15       Impact factor: 9.867

6.  Human papillomavirus type 16 E7 oncoprotein-induced abnormal centrosome synthesis is an early event in the evolving malignant phenotype.

Authors:  S Duensing; A Duensing; C P Crum; K Münger
Journal:  Cancer Res       Date:  2001-03-15       Impact factor: 12.701

7.  Dissection of human papillomavirus E6 and E7 function in transgenic mouse models of cervical carcinogenesis.

Authors:  Rebeccah R Riley; Stefan Duensing; Tiffany Brake; Karl Münger; Paul F Lambert; Jeffrey M Arbeit
Journal:  Cancer Res       Date:  2003-08-15       Impact factor: 12.701

8.  Human papillomavirus type 16 E2 protein has no effect on transcription from episomal viral DNA.

Authors:  Viviane Bechtold; Peter Beard; Kenneth Raj
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

9.  Transcription-independent triggering of the extrinsic pathway of apoptosis by human papillomavirus 18 E2 protein.

Authors:  Caroline Demeret; Alejandro Garcia-Carranca; Françoise Thierry
Journal:  Oncogene       Date:  2003-01-16       Impact factor: 9.867

10.  Mutational analysis of the adenovirus E1a gene: the role of transcriptional regulation in transformation.

Authors:  J F Schneider; F Fisher; C R Goding; N C Jones
Journal:  EMBO J       Date:  1987-07       Impact factor: 11.598

View more
  25 in total

1.  Targeting the human papillomavirus E6 and E7 oncogenes through expression of the bovine papillomavirus type 1 E2 protein stimulates cellular motility.

Authors:  Monique A Morrison; Richard J Morreale; Shailaja Akunuru; Matthew Kofron; Yi Zheng; Susanne I Wells
Journal:  J Virol       Date:  2011-08-10       Impact factor: 5.103

2.  Cervical keratinocytes containing stably replicating extrachromosomal HPV-16 are refractory to transformation by oncogenic H-Ras.

Authors:  Kristi L Berger; Felicia Barriga; Michael J Lace; Lubomir P Turek; Gideon J Zamba; Frederick E Domann; John H Lee; Aloysius J Klingelhutz
Journal:  Virology       Date:  2006-08-30       Impact factor: 3.616

Review 3.  Replication and partitioning of papillomavirus genomes.

Authors:  Alison A McBride
Journal:  Adv Virus Res       Date:  2008       Impact factor: 9.937

4.  The Mdm2 ubiquitin ligase enhances transcriptional activity of human papillomavirus E2.

Authors:  Noor Gammoh; Daniela Gardiol; Paola Massimi; Lawrence Banks
Journal:  J Virol       Date:  2008-11-12       Impact factor: 5.103

5.  Type-specific interaction between human papillomavirus type 58 E2 protein and E7 protein inhibits E7-mediated oncogenicity.

Authors:  Xin Wang; Mei Qi; Xiuping Yu; Yan Yuan; Weiming Zhao
Journal:  J Gen Virol       Date:  2012-03-21       Impact factor: 3.891

Review 6.  Human Papillomavirus E2 Protein: Linking Replication, Transcription, and RNA Processing.

Authors:  Sheila V Graham
Journal:  J Virol       Date:  2016-09-12       Impact factor: 5.103

7.  HPV-16 E2 contributes to induction of HPV-16 late gene expression by inhibiting early polyadenylation.

Authors:  Cecilia Johansson; Monika Somberg; Xiaoze Li; Ellenor Backström Winquist; Joanna Fay; Fergus Ryan; David Pim; Lawrence Banks; Stefan Schwartz
Journal:  EMBO J       Date:  2012-05-22       Impact factor: 11.598

8.  Tumor suppressor or oncogene? A critical role of the human papillomavirus (HPV) E2 protein in cervical cancer progression.

Authors:  Sophie Bellanger; Chye Ling Tan; Yue Zhen Xue; Sébastien Teissier; Françoise Thierry
Journal:  Am J Cancer Res       Date:  2011-01-24       Impact factor: 6.166

9.  Viral load, gene expression and mapping of viral integration sites in HPV16-associated HNSCC cell lines.

Authors:  Nadine C Olthof; Christian U Huebbers; Jutta Kolligs; Mieke Henfling; Frans C S Ramaekers; Iris Cornet; Josefa A van Lent-Albrechts; Alexander P A Stegmann; Steffi Silling; Ulrike Wieland; Thomas E Carey; Heather M Walline; Susanne M Gollin; Thomas K Hoffmann; Johan de Winter; Bernd Kremer; Jens P Klussmann; Ernst-Jan M Speel
Journal:  Int J Cancer       Date:  2014-08-14       Impact factor: 7.396

10.  Robust production and passaging of infectious HPV in squamous epithelium of primary human keratinocytes.

Authors:  Hsu-Kun Wang; Aaron A Duffy; Thomas R Broker; Louise T Chow
Journal:  Genes Dev       Date:  2009-01-08       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.